RE: Hunt for a Versatile Respiratory Virus Killer14 Feb 2023 17:28
Professional - I think if there was a fundraise, it would only be to fund a new trial. No one would take part if it was just to continue paying the salaries and pension. If a new P3 trial was the reason then you would expect the SP to rise quite quickly and significantly, or at least to the 40-70p being bandied about on this thread. So I don’t think investors would need long to make some money. Of course, there are LTHs here with average in prices of £2… that could be a stretch perhaps. But on the flip side you could also argue the odds of failing two P3’s would be less than one, so the market could price it higher.
All guesswork. And hopefully we can have a go at a sensible debate.
Even I’m getting frustrated at the lack of updates. The job advert and possible connection to BP are, like Gunto, keeping me interested.